Arkolith/Insider Trading/RVMD/Form 4

Horn Margaret A

Chief Operating OfficerRevolution Medicines, Inc. (RVMD) · full profile →Form 4 · filed Jun 15, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.5M
Net Open-Market Flow
-$1.5M
Transactions
11
9 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 11, 2026Option exercise(M)1K$42.45$46K159K
Jun 11, 2026Option exercise(M)9K$40.74$363K168K
Jun 11, 2026Sell(S)1K$144.28$190K167K
Jun 11, 2026Sell(S)885$145.15$128K166K
Jun 11, 2026Sell(S)700$146.04$102K165K
Jun 11, 2026Sell(S)500$147.27$74K165K
Jun 11, 2026Sell(S)2K$148.72$268K163K
Jun 11, 2026Sell(S)5K$149.64$688K158K
Jun 11, 2026Sell(S)200$150.17$30K158K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 11, 2026Option exercise(M)1K—$00
Jun 11, 2026Option exercise(M)9K—$091K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001610717-26-000216) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML